Sep 27, 2017 7:00 am EDT Pelican Therapeutics Announces Manufacturing Agreement with KBI Biopharma to Advance Cancer-targeting Immunotherapies
Sep 12, 2017 7:00 am EDT Heat Biologics Granted Type C Meeting with FDA to Discuss Registrational Pathway for HS-110 in Combination with Opdivo(R) as a Treatment for Non-Small Cell Lung Cancer
Sep 07, 2017 7:00 am EDT Heat Biologics to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York
Jun 28, 2017 7:00 am EDT Pelican Therapeutics, a Subsidiary of Heat Biologics, Receives First Tranche of $15.2 Million CPRIT Grant Award